Insider Trading activities at Agile Therapeutics Inc (AGRX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agile Therapeutics Inc (AGRX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agile Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1261249.

Total stock buying since 2014: $79,257,273.
Total stock sales since 2014: $2,369,943.
Total stock option exercises since 2014: $436,190.


18 insiders reported insider trading activities at Agile Therapeutics Inc (AGRX):
Insider trading activities of Mckee William
Insider trading activities of Selman Renee
Insider trading activities of Conway Robert G
Insider trading activities of Schiff Andrew N
Insider trading activities of Altomari Alfred
Insider trading activities of Hubbard John W
Insider trading activities of Coiante Scott M
Insider trading activities of Fischer Seth H. Z.
Insider trading activities of Care Capital Offshore Investments Iii Lp
Insider trading activities of Garner Elizabeth
Insider trading activities of Investor Ab
Insider trading activities of Proquest Associates Iv Llc
Insider trading activities of Reilly Dennis
Insider trading activities of Shetty Ajit
Insider trading activities of Tursi James Patrick
Insider trading activities of Lele Abhijeet J
Insider trading activities of Gilmore Geoffrey
Insider trading activities of Edelman Joseph

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Agile Therapeutics Inc (AGRX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2022 50,000 $22,500 0 $0 0 $0
2021 6,030,908 $5,148,339 0 $0 0 $0
2020 4,094,000 $10,977,875 0 $0 165,289 $273,540
2019 8,133,815 $12,012,995 4,575,640 $2,280,355 147,554 $0
2018 0 $0 298,628 $89,588 194,361 $0
2017 80,583 $289,052 0 $0 53,667 $79,050
2016 393,700 $2,499,995 0 $0 16,666 $0
2015 1,626,432 $9,521,827 0 $0 17,500 $30,800
2014 6,464,115 $38,784,690 0 $0 30,000 $52,800

Table 2. Monthly summary of insider trading at Agile Therapeutics Inc (AGRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2022-08 50,000 $22,500 0 $0 0 $0
2021-10 5,852,208 $4,874,376 0 $0 0 $0
2021-07 76,200 $87,240 0 $0 0 $0
2021-05 40,000 $59,200 0 $0 0 $0
2021-03 62,500 $127,523 0 $0 0 $0
2020-11 0 $0 0 $0 4,149 $7,302
2020-09 9,000 $25,650 0 $0 0 $0
2020-08 0 $0 0 $0 94,599 $166,494
2020-06 0 $0 0 $0 50,000 $88,000
2020-03 1,075,000 $1,925,125 0 $0 0 $0
2020-02 3,010,000 $9,027,100 0 $0 16,541 $11,744
2019-11 5,768,815 $9,733,295 0 $0 0 $0
2019-10 0 $0 4,575,640 $2,280,355 0 $0
2019-08 2,300,000 $2,185,000 0 $0 0 $0
2019-06 20,000 $25,400 0 $0 0 $0
2019-03 45,000 $69,300 0 $0 0 $0
2019-01 0 $0 0 $0 147,554 $0
2018-07 0 $0 298,628 $89,588 0 $0
2018-06 0 $0 0 $0 107,694 $0
2018-02 0 $0 0 $0 16,667 $0
2018-01 0 $0 0 $0 70,000 $0
2017-08 17,250 $57,687 0 $0 0 $0
2017-06 0 $0 0 $0 7,000 $26,250
2017-05 63,333 $231,365 0 $0 0 $0

Table 3. Detailed insider trading at Agile Therapeutics Inc (AGRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-08-26 Altomari Alfred (Chief Executive Officer) Buy 50,000 .45 22,500
2021-10-13 Reilly Dennis (Chief Financial Officer) Buy 58,824 .00 0
2021-10-13 Altomari Alfred (Chief Executive Officer) Buy 58,824 .00 0
2021-10-13 Edelman Joseph (10% Owner) Buy 5,734,560 .85 4,874,376
2021-07-29 Altomari Alfred (Chief Executive Officer) Buy 26,200 1.26 33,090
2021-07-27 Reilly Dennis (Chief Financial Officer) Buy 50,000 1.08 54,150
2021-05-18 Altomari Alfred (Chief Executive Officer) Buy 20,000 1.61 32,200
2021-05-11 Reilly Dennis (Chief Financial Officer) Buy 20,000 1.35 27,000
2021-03-23 Reilly Dennis (Chief Financial Officer) Buy 50,000 2.05 102,499
2021-03-23 Altomari Alfred (Chief Executive Officer) Buy 12,500 2.00 25,024
2020-11-19 Conway Robert G (SVP Chief Supply Chain Officer) Option Ex 4,149 1.76 7,302
2020-09-28 Reilly Dennis (Chief Financial Officer) Buy 9,000 2.85 25,650
2020-08-20 Altomari Alfred (Chief Executive Officer) Option Ex 94,599 1.76 166,494
2020-06-22 Altomari Alfred (Chief Executive Officer) Option Ex 50,000 1.76 88,000
2020-03-13 Edelman Joseph (10% Owner) Buy 1,000,000 1.75 1,750,000
2020-03-04 Reilly Dennis (Chief Financial Officer) Buy 75,000 2.33 175,125
2020-02-27 Altomari Alfred (Chief Executive Officer) Buy 10,000 2.71 27,100
2020-02-27 Altomari Alfred (Chief Executive Officer) Option Ex 16,541 .71 11,744
2020-02-25 Edelman Joseph (10% Owner) Buy 3,000,000 3.00 9,000,000
2019-11-15 Edelman Joseph (10% Owner) Buy 5,333,800 1.69 8,998,120
2019-11-14 Edelman Joseph (10% Owner) Buy 435,015 1.69 735,175
2019-10-29 Edelman Joseph (10% Owner) Sale 760,291 .44 334,528
2019-10-28 Edelman Joseph (10% Owner) Sale 3,815,349 .51 1,945,827
2019-08-06 Edelman Joseph (10% Owner) Buy 2,300,000 .95 2,185,000
2019-06-10 Altomari Alfred (Chief Executive Officer) Buy 20,000 1.27 25,400
2019-03-29 Lele Abhijeet J (Director) Buy 20,000 1.54 30,800
2019-03-25 Altomari Alfred (Chief Executive Officer) Buy 25,000 1.54 38,500
2019-01-25 Garner Elizabeth (Sr. VP & Chief Medical Officer) Option Ex 17,500 .00 0
2019-01-25 Coiante Scott M (Chief Financial Officer) Option Ex 17,500 .00 0
2019-01-25 Gilmore Geoffrey (General Counsel) Option Ex 17,500 .00 0
2019-01-24 Conway Robert G (SVP Ent Planning & Info Mgt) Option Ex 8,625 .00 0
2019-01-24 Garner Elizabeth (Sr. VP & Chief Medical Officer) Option Ex 18,565 .00 0
2019-01-24 Coiante Scott M (Chief Financial Officer) Option Ex 16,070 .00 0
2019-01-24 Gilmore Geoffrey (General Counsel) Option Ex 16,480 .00 0
2019-01-24 Altomari Alfred (Chief Executive Officer) Option Ex 35,314 .00 0
2018-07-26 Edelman Joseph (Other) Sale 298,628 .30 89,588
2018-06-08 Shetty Ajit (Director) Option Ex 17,949 .00 0
2018-06-08 Hubbard John W (Director) Option Ex 17,949 .00 0
2018-06-08 Fischer Seth H. Z. (Director) Option Ex 17,949 .00 0
2018-06-08 Tursi James Patrick (Director) Option Ex 17,949 .00 0
2018-06-08 Lele Abhijeet J (Director) Option Ex 17,949 .00 0
2018-06-08 Mckee William (Director) Option Ex 17,949 .00 0
2018-02-08 Altomari Alfred (Chief Executive Officer) Option Ex 16,667 .00 0
2018-01-25 Selman Renee (Chief Commercial Officer) Option Ex 17,500 .00 0
2018-01-25 Garner Elizabeth (Sr. VP & Chief Medical Officer) Option Ex 17,500 .00 0
2018-01-25 Coiante Scott M (Chief Financial Officer) Option Ex 17,500 .00 0
2018-01-25 Gilmore Geoffrey (General Counsel) Option Ex 17,500 .00 0
2017-08-25 Selman Renee (Chief Commercial Officer) Buy 7,250 3.35 24,287
2017-08-25 Altomari Alfred (Chairman & Chief Executive Officer) Buy 10,000 3.34 33,400
2017-06-12 Shetty Ajit (Director) Option Ex 7,000 3.75 26,250
2017-05-11 Selman Renee (Chief Commercial Officer) Buy 53,333 3.68 196,265
2017-05-11 Altomari Alfred (Chairman and Chief Executive O) Buy 10,000 3.51 35,100
2017-04-11 Altomari Alfred (Chairman & Chief Exec Officer) Option Ex 30,000 1.76 52,800
2017-02-08 Altomari Alfred (Chief Executive Officer) Option Ex 16,667 .00 0
2016-02-08 Altomari Alfred (Chief Executive Officer) Option Ex 16,666 .00 0
2016-01-27 Proquest Associates Iv Llc (10% Owner) Buy 393,700 6.35 2,499,995
2015-06-02 Altomari Alfred (Chief Executive Officer) Buy 2,500 8.73 21,825
2015-03-11 Altomari Alfred (Chief Executive Officer) Option Ex 17,500 1.76 30,800
2015-01-23 Proquest Associates Iv Llc (10% Owner) Buy 811,966 5.85 4,750,001
2015-01-23 Schiff Andrew N Buy 811,966 5.85 4,750,001
2014-12-18 Altomari Alfred (Chief Executive Officer) Option Ex 30,000 1.76 52,800
2014-05-29 Care Capital Offshore Investments Iii Lp (10% Owner) Buy 500,000 6.00 3,000,000
2014-05-29 Proquest Associates Iv Llc (10% Owner) Buy 1,120,833 6.00 6,724,998
2014-05-29 Investor Ab Buy 2,509,949 6.00 15,059,694
2014-05-23 Schiff Andrew N Buy 1,333,333 6.00 7,999,998
2014-05-22 Investor Ab Buy 1,000,000 6.00 6,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of AGRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agile Therapeutics Inc (symbol AGRX, CIK number 1261249) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.